OpenAI has acquired Orchestra Bio, a four-year-old startup that develops artificial intelligence (AI) software for biotechnology companies, as the company expands its tools for life sciences research.
OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announcedtartup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC
